Related Experiment Video
Updated: Aug 18, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Is Pneumocystis carinii pneumonia after stem cell transplantations a contagious disease?
Igor B Resnick1, Diana Averbuch, Memet Aker
1Bone Marrow Transplantation and Cancer Immunotherapy, Hadassah Medical Center, Hebrew University, Hadassah Medical School, Jerusalem, Israel.
Insights
Pneumocystis pneumonia (PCP) may be contagious in hematopoietic stem cell transplant (HSCT) recipients. This risk is heightened in infants and young children, necessitating careful avoidance strategies to prevent infection transmission.
Area of Science:
- Pediatric Hematology
- Infectious Diseases
- Transplantation Immunology
Background:
- Neonatal acute leukemia presents a critical challenge requiring aggressive treatment like hematopoietic stem cell transplantation (HSCT).
- HSCT recipients are profoundly immunocompromised, increasing susceptibility to opportunistic infections.
- Pneumocystis jiroveci pneumonia (PCP) is a significant threat in immunocompromised populations, particularly after transplantation.
Observation:
- Identical twins undergoing HSCT for neonatal acute leukemia were hospitalized together.
- The first twin developed respiratory symptoms, followed by the second twin developing Pneumocystis jiroveci pneumonia (PCP) two weeks later.
- Both twins were housed in the same room throughout their hospitalization.
Findings:
- The sequential development of PCP in twins treated in close proximity suggests potential contagion.
- This case highlights the possibility of person-to-person transmission of Pneumocystis jiroveci in a highly vulnerable HSCT recipient population.
- The timing of PCP onset in both twins indicates a possible incubation period and transmission event.
Implications:
- PCP may be transmissible between hematopoietic stem cell transplant recipients, especially infants and young children.
- Enhanced infection control measures and isolation protocols may be necessary for HSCT units, particularly for pediatric patients.
- Further research is warranted to elucidate the transmission dynamics of Pneumocystis jiroveci in HSCT recipients to refine preventative strategies.
Abstract:
We report of twins who underwent hematopoietic stem cell transplantation (HSCT) for neonatal acute leukemia. Hospitalized in the same room from the time the first one demonstrated respiratory symptoms, they both developed Pneumocystis jiroveci (formerly carinii) pneumonia (PCP) 2 wk apart. This observation suggests that PCP may be a contagious disease in HSCT recipients. This may be especially true for infants and young children who are at risk of primary P. jiroveci infection, and should be avoided.
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction
Cryptococcal Meningitis
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Cytomegalovirus Disease
